Key Points:
·Key data: Sweden's smoking rate has dropped to 5.3%, close to the "smoke-free country" standard (5%). The rate of women quitting smoking has increased by nearly 200%, the male lung cancer mortality rate is 61% lower than the EU average, and the overall cancer mortality rate is 34% lower.
·Research findings conclude that nicotine pouches are one of the most effective methods for helping smokers (especially women) quit smoking. They are considered safe, socially acceptable, and adaptable to modern lifestyles.
According to a report from Antara News on June 18, a new study from smoke-free Sweden suggests that oral nicotine pouches are changing the landscape towards Sweden becoming the first smoke-free country in the world - and are driving unprecedented success among women. The report titled "Power in a Pouch", released on June 17 in Strasbourg, shows that since their introduction in 2016, smoke-free pouches have helped accelerate the decline in smoking rates for both men and women, with a nearly 200% increase in female cessation rates. Sweden currently has a smoking rate of 5.3%, just above the 5% smoke-free benchmark. Male lung cancer death rates are 61% lower than the EU average; overall cancer death rates are 34% lower.
The co-author of the report, Dr. X, stated:
"The evidence is clear: nicotine pouches are the most effective method to help smokers, especially women, quit smoking."
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
